What are the indications for cardiac resynchronization therapy with defibrillator (CRT‑D)?

Indications for Cardiac Resynchronization Therapy with Defibrillator (CRT-D)

CRT-D is indicated for patients with heart failure on guideline-directed medical therapy (GDMT) for ≥3 months (or ≥40 days post-MI) who have LVEF ≤35%, NYHA class II-IV symptoms, sinus rhythm, LBBB pattern with QRS ≥150 ms, and reasonable life expectancy (>1 year with good functional capacity). 1

Core Eligibility Criteria

All patients being considered for CRT-D must meet these fundamental requirements 1:

• LVEF ≤35% despite optimal medical therapy
• On GDMT for ≥3 months (or ≥40 days if post-myocardial infarction)
• Acceptable non-cardiac health with life expectancy >1 year with good functional capacity
• No refractory NYHA class IV symptoms dependent on intravenous inotropes (except selected transplant candidates)

Class I Indications (Strongest Evidence)

NYHA Class II-III with LBBB

For patients with LVEF ≤35%, sinus rhythm, LBBB pattern with QRS ≥150 ms, and NYHA class II, III, or ambulatory class IV symptoms, CRT-D is recommended to reduce total mortality, reduce hospitalizations, and improve symptoms and quality of life. 1

This represents the strongest indication, supported by multiple randomized controlled trials demonstrating clear mortality benefit 2. The LBBB pattern is critical—evidence is strongest for this conduction abnormality 1.

NYHA Class I with Specific Features

For highly selected NYHA class I patients with LVEF ≤30%, ischemic cardiomyopathy, sinus rhythm, LBBB pattern with QRS ≥150 ms, CRT-D may be considered to reduce hospitalizations 1. However, this is a Class IIb recommendation (weaker evidence) 1.

Class IIa Indications (Reasonable to Use)

LBBB with QRS 120-149 ms

For patients with LVEF ≤35%, sinus rhythm, LBBB pattern with QRS 120-149 ms, and NYHA class II-III symptoms, CRT-D can be useful to reduce mortality and hospitalizations. 1

Special Pacing Indications

CRT-D is reasonable for patients with LVEF ≤35% who require frequent ventricular pacing (>40%) or are undergoing new/replacement device implantation with anticipated significant ventricular pacing. 1

Atrial Fibrillation

In patients with atrial fibrillation, LVEF ≤35%, and NYHA class III-IV symptoms, CRT-D can be useful if atrioventricular nodal ablation or pharmacological rate control will allow near 100% ventricular pacing. 1 The ESC guidelines specify ≥95% pacemaker dependency as the threshold 1.

Class IIb Indications (May Be Considered)

Non-LBBB Patterns

For patients with non-LBBB pattern and QRS 120-149 ms, CRT-D may be considered only in NYHA class III or ambulatory class IV. 1 This is weaker evidence because non-LBBB patterns show less consistent benefit 1.

For non-LBBB pattern with QRS ≥150 ms and NYHA class II symptoms, CRT-D may be considered. 1

Class III (Not Recommended)

CRT-D is NOT recommended in the following scenarios 1:

• QRS duration <120 ms (no benefit demonstrated) 1
• NYHA class I or II with non-LBBB pattern and QRS <150 ms 1
• Comorbidities or frailty limiting survival with good functional capacity to <1 year 1
• Refractory NYHA class IV with inotrope dependence (except selected transplant/LVAD candidates) 1

CRT-D vs CRT-P Decision

For NYHA class I-II patients, CRT-D is anticipated over CRT-P (pacemaker only) because benefit has only been shown in CRT-D trials, though CRT-P may be appropriate based on clinical reasons or patient wishes. 1

For NYHA class III and ambulatory class IV patients, either CRT-D or CRT-P may be chosen, but CRT-P is appropriate when an ICD is not expected to produce meaningful survival benefit. 1 This includes patients with significant comorbidities, advanced age, or nonischemic cardiomyopathy without arrhythmia history 3, 4.

Critical Caveats

• Optimize GDMT first: Patients should be on maximally tolerated evidence-based doses of ACE inhibitors/ARBs, beta-blockers, and mineralocorticoid receptor antagonists before device consideration 1
• Timing matters: Avoid implantation during acute decompensated heart failure; stabilize and reassess as outpatient 1
• QRS morphology is crucial: LBBB pattern has the strongest evidence; non-LBBB patterns require longer QRS duration (≥150 ms) for similar benefit 1
• Sinus rhythm preferred: Most evidence supports CRT-D in sinus rhythm; atrial fibrillation requires near-complete ventricular capture 1